Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication
DARU Journal of Pharmaceutical Sciences · 2024
DOI: 10.1007/s40199-024-00524-z ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift DARU Journal of Pharmaceutical Sciences, 2024. Verfasst von Swarnali Das und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, 208016, India. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19 Drug Treatment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Institute of Eminence, University of Delhi.
Abstract (Originalsprache)
BACKGROUND: COVID-19 pandemic has turned our world upside down by meddling with our normal lives. While there is no definitive drug against SARS-CoV-2, antiviral drugs that are already in the market, are being repurposed against it, could now complete long-term as well as all age-specific investigations, and they are successful in saving millions of lives. Nevertheless, side-effects are emergingly seen in the patients undergoing treatment, and ineffectiveness is increasingly found due to the emerging notorious variants of the virus. Many of them are also facing serious co-infections including black fungus, Zika, and H1N1 virus to name a few. OBJECTIVES: Therefore, this review highlights both drug resistance, their side-effects, and the significance for proper and long-term clinical trials of all age groups including children. METHODS: We have explored and proposed the mechanisms of drug resistance that may arise due to the misuse or overuse of drugs based on available experimental reports. RESULTS: The review provides solutions to the aforesaid issues of drug-resistance and side-effects by providing combination therapies, ancillary treatments, and other preventive strategies that can be useful in preventing drawbacks thereby curbing COVID-19 or similar future infections to maintain our normal lives. CONCLUSION: COVID-19 and its long-term effects, if any, can be eradicated with strategic and mindful use of related therapeutics in a controlled manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, 208016, India.
- Imaging Cell Signaling and Therapeutics Lab, Advanced Centre for Training Research and Education in Cancer, Navi Mumbai, 410210, India.
- Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India.
- Laboratory for Structural Biology of Membrane Proteins, Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India.
- Laboratory for Structural Biology of Membrane Proteins, Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India. sdey@acbr.du.ac.in.
Förderung
- Institute of Eminence, University of Delhi
Zitieren
APA
Das, S., Nath, S., Shahjahan, & Dey, S. K. (2024). Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication. DARU Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-024-00524-z
Vancouver
Das S, Nath S, Shahjahan, Dey SK. Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication. DARU Journal of Pharmaceutical Sciences. 2024. doi:10.1007/s40199-024-00524-z
BibTeX
@article{Das2024,
author = {Das, Swarnali and Nath, Sreyashi and Shahjahan and Dey, Sanjay Kumar},
title = {Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication},
journal = {DARU Journal of Pharmaceutical Sciences},
year = {2024},
doi = {10.1007/s40199-024-00524-z}
}
EUVIMED